Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
about
Secondary syphilis: the classical triad of skin rash, mucosal ulceration and lymphadenopathyGlobal Challenge of Antibiotic-Resistant Treponema pallidumGenetic diversity in Treponema pallidum: implications for pathogenesis, evolution and molecular diagnostics of syphilis and yawsOrigin of modern syphilis and emergence of a pandemic Treponema pallidum cluster.Azithromycin-resistant syphilis-causing strains in Sydney, Australia: prevalence and risk factorsMolecular typing of Treponema pallidum: a systematic review and meta-analysis.Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy.Molecular typing of Treponema pallidum in the Czech Republic during 2011 to 2013: increased prevalence of identified genotypes and of isolates with macrolide resistance.Sexually transmitted diseases treatment guidelines, 2015.Characterizing the syphilis epidemic among men who have sex with men in Lima, Peru to identify new treatment and control strategies.Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai.Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis.Treponema pallidum putative novel drug target identification and validation: rethinking syphilis therapeutics with plant-derived terpenoids.High frequency of the 23S rRNA A2058G mutation of Treponema pallidum in Shanghai is associated with a current strategy for the treatment of syphilisCanadian guidelines on sexually transmitted infections, 2006Syphilis: using modern approaches to understand an old disease.High Resistance to Azithromycin in Clinical Samples from Patients with Sexually Transmitted Diseases in Guangxi Zhuang Autonomous Region, ChinaEvaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study.Molecular typing of Treponema pallidum isolates from Buenos Aires, Argentina: Frequent Nichols-like isolates and low levels of macrolide resistanceDetection of the A2058G and A2059G 23S rRNA gene point mutations associated with azithromycin resistance in Treponema pallidum by use of a TaqMan real-time multiplex PCR assayAntimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillanceTwo mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington.Sexual health and HIV in travellers and expatriates.Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar.Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.Macrolide Resistance in Treponema pallidum Correlates With 23S rDNA Mutations in Recently Isolated Clinical StrainsMolecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabsOn the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infectionsEfficacy of Doxycycline in the Treatment of Syphilis.Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals.Current standards for diagnosis and treatment of syphilis: selection of some practical issues, based on the European (IUSTI) and U.S. (CDC) guidelinesGenome-scale analysis of the non-cultivable Treponema pallidum reveals extensive within-patient genetic variation.Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?Syphilis epidemiology in 1994-2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013-2014 in Tuva Republic, Russia.Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection.The molecular epidemiology of Treponema pallidum subspecies pallidumDetection of azithromycin resistance in Treponema pallidum by real-time PCR.Two mutations associated with macrolide resistance in Treponema pallidum in Shandong, China.The endemic treponematoses
P2860
Q22241585-B3F5E889-9F25-4F7A-B729-19FBFB3C87B9Q22242241-34DE2F68-2400-4AE6-8240-6342419FFE37Q27024345-E9808308-2746-44D6-AB7B-3961817513E8Q30396026-49EA2066-9DE8-4A1C-885B-7C4754C849E4Q34058681-D260661E-AA48-4DEB-A0A3-18DA47B6BA7BQ34075745-5AF56D2F-0154-4C49-B5C7-228687DDDBBBQ34112510-B58E4975-8DF5-4477-9A12-9253AEE51EEAQ34298077-46B3DDFA-A4EF-48FD-B9E0-E046ECB7CC67Q34479272-9B5626C1-9CCC-4F03-94A5-C9248ACFA2CBQ34982092-0347700B-EDAB-401F-93B7-4BE6D92A3FFDQ35044203-C52F40DA-D5C4-4970-B3E4-2258A1E27D59Q35044226-BF9F99C5-322D-4619-99BB-F617F97D78ADQ35067843-E2A1E2C4-B508-4D48-85B8-51F17B98A3A0Q35133876-CBD3D134-1838-4C3C-AD59-26B106117147Q35575064-517AF759-C8C8-4995-A259-CED977358203Q35578589-853BAA49-D612-4EBE-A24C-4FB3972C851DQ36088424-58439BDD-A605-46DE-A669-D3D02D6A9DDDQ36118760-431A024E-65C3-4B3F-9F69-6552823C1C23Q36290350-E0E3DA46-0F9D-45CD-9FDD-9E19F24AA9D5Q36667643-1E76C1AD-0A64-4029-8CF3-39CA6A767F0DQ36723212-8FEDFC68-D57C-4E5B-BD88-DFF33C6007DFQ36889610-74D9A719-FF4E-417B-BD8C-87FC0EDB6B5EQ36893301-2A384E7C-F519-45BF-A142-F18CDFEDB3B9Q36904510-BC764862-E900-4584-ADB6-8C13C519D188Q37076814-E649108B-1D45-484C-B0EB-DDC10A70D4A0Q37170980-33147AA6-59B0-4C92-B4B8-7546E0447BABQ37213948-D0FAAF8A-7481-4036-B312-9F170194A433Q37530197-575D5B7A-2487-42DF-9FC7-985E50988799Q37538743-DC9A918F-E97F-4C18-AF70-F48D93055BAAQ37606376-EFDE6B6C-98C8-4C67-8F74-FFAF8DFDB539Q38166343-B8F064A2-0343-45B8-9424-85020F47C74EQ39283161-50FD25E9-66F5-4BC9-A733-C824A84B7D29Q40689047-19B6ED41-A950-4A2C-9C3D-1C3BA21EDC5DQ40704181-7AC6B6B9-3332-4815-843B-D38C21A72185Q40896237-4300DEDB-76F1-4626-874B-FF86000EC4C7Q42615973-B23E5787-F378-4FC6-8971-69E03E374BB4Q42627564-79D7294B-8BED-4F1F-B8F0-68FA0485FCD6Q42872001-8682CDF5-9A48-4597-9A52-4CF2C522CD6AQ54262687-87EA622E-2361-4169-9984-AD6D46FD5E54
P2860
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@ast
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@en
type
label
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@ast
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@en
prefLabel
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@ast
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@en
P2093
P921
P356
P1476
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
@en
P2093
Charlotte K Kent
Charmie Godornes
Joseph Engelman
Samuel J Mitchell
Sheila A Lukehart
P304
P356
10.1086/498899
P407
P577
2005-12-28T00:00:00Z